Joanne Wuensch
Stock Analyst at Citigroup
(4.27)
# 393
Out of 5,057 analysts
426
Total ratings
61.75%
Success rate
11.02%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Maintains: Neutral | $77 → $69 | $68.05 | +1.40% | 8 | Nov 3, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $12 → $11 | $12.04 | -8.64% | 16 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $26 → $21 | $18.70 | +12.30% | 22 | Oct 31, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $205 → $242 | $168.50 | +43.62% | 22 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $96 | $86.11 | +11.49% | 21 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $85 → $75 | $59.72 | +25.59% | 16 | Oct 31, 2025 | |
| GKOS Glaukos | Maintains: Buy | $110 → $113 | $91.81 | +23.08% | 22 | Oct 30, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $213 → $215 | $195.25 | +10.12% | 15 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $11 → $15 | $17.53 | -14.43% | 20 | Oct 7, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4.5 → $4 | $7.05 | -43.26% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $96.14 | +16.50% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $64 | $73.91 | -13.41% | 9 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $83 | $73.97 | +12.21% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $97 → $72 | $71.75 | +0.35% | 21 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $129.26 | +19.91% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $320 → $285 | $278.74 | +2.25% | 25 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $47 | $64.75 | -27.41% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $15.69 | -4.40% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $373.42 | +21.85% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.59 | +161.01% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $565.51 | +14.94% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $332.67 | +14.23% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $104.98 | +19.07% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $90.57 | +32.49% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $193.04 | +29.51% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $78.61 | -12.22% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $252.11 | -49.63% | 6 | Dec 10, 2018 |
Integer Holdings
Nov 3, 2025
Maintains: Neutral
Price Target: $77 → $69
Current: $68.05
Upside: +1.40%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $12.04
Upside: -8.64%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $18.70
Upside: +12.30%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $168.50
Upside: +43.62%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $95 → $96
Current: $86.11
Upside: +11.49%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $85 → $75
Current: $59.72
Upside: +25.59%
Glaukos
Oct 30, 2025
Maintains: Buy
Price Target: $110 → $113
Current: $91.81
Upside: +23.08%
Johnson & Johnson
Oct 15, 2025
Maintains: Buy
Price Target: $213 → $215
Current: $195.25
Upside: +10.12%
Tandem Diabetes Care
Oct 7, 2025
Maintains: Neutral
Price Target: $11 → $15
Current: $17.53
Upside: -14.43%
Sight Sciences
Oct 7, 2025
Maintains: Neutral
Price Target: $4.5 → $4
Current: $7.05
Upside: -43.26%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $96.14
Upside: +16.50%
Oct 7, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $73.91
Upside: -13.41%
Oct 7, 2025
Downgrades: Neutral
Price Target: $93 → $83
Current: $73.97
Upside: +12.21%
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $71.75
Upside: +0.35%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $129.26
Upside: +19.91%
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $278.74
Upside: +2.25%
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $64.75
Upside: -27.41%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $15.69
Upside: -4.40%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $373.42
Upside: +21.85%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.59
Upside: +161.01%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $565.51
Upside: +14.94%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $332.67
Upside: +14.23%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $104.98
Upside: +19.07%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $90.57
Upside: +32.49%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $193.04
Upside: +29.51%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $78.61
Upside: -12.22%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $252.11
Upside: -49.63%